Actavis Partly Settles Generic Delay Case Over Shire’s Intuniv

Teva Pharmaceutical Industries Ltd. unit Actavis Inc. has settled part of a sprawling antitrust lawsuit in Boston federal court claiming it conspired with Takeda Pharmaceuticals Co. subsidiary Shire PLC to delay generic versions of Shire’s ADHD drug Intuniv.

The agreement, disclosed in a court filing Wednesday, resolves class action claims against Actavis by “direct purchasers” like wholesalers and major pharmacy chains that are challenging an earlier patent settlement between the two drugmakers.

It doesn’t affect the claims against Shire or those brought by a separate proposed class of “indirect purchasers” like insurers. The deal’s terms weren’t included in the filing, ...